Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

  • Post author:
  • Post category:uncategorized

In a step forward for breast cancer treatment, researchers at Tohoku University have developed a novel monoclonal antibody which specifically targets a certain type of breast cancer cell.